Improving Diversity in Clinical Trials by Using Real-world Data to Define Eligibility Criteria
Author:
Affiliation:
1. Flatiron Health, Inc, New York, New York
2. Department of Radiation Oncology, Wake Forest University School of Medicine, Winston-Salem, North Carolina
Abstract
Publisher
American Medical Association (AMA)
Subject
Oncology,Cancer Research
Link
https://jamanetwork.com/journals/jamaoncology/articlepdf/2801293/jamaoncology_royce_2023_vp_220029_1681755636.87426.pdf
Reference7 articles.
1. Racial and ethnic disparities among participants in precision oncology clinical studies.;Aldrighetti;JAMA Netw Open,2021
2. Striving for diversity in research studies.;Rubin;N Engl J Med,2021
3. In search of a better equation—performance and equity in estimates of kidney function.;Diao;N Engl J Med,2021
4. Eligibility criteria perpetuate disparities in enrollment and participation of black patients in pancreatic cancer clinical trials.;Riner;J Clin Oncol,2022
5. US Food and Drug Administration. Diversity plans to improve enrollment of participants from underrepresented racial and ethnic populations in clinical trials; draft guidance for industry. April 2022. Accessed April 13, 2022. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/diversity-plans-improve-enrollment-participants-underrepresented-racial-and-ethnic-populations
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Applying an ELSI lens to real-world data and novel genomic insights for personalized mental healthcare;Frontiers in Genetics;2024-08-14
2. Artificial intelligence and nonoperating room anesthesia;Current Opinion in Anaesthesiology;2024-05-17
3. Genetic Ancestry and Somatic Mutations in Lung Adenocarcinoma: Insights from Real-World Clinico-Genomic Data;2024-04-25
4. Incorporating Real-World Clinico-Genomic Insights to Inform Diversity Enrollment Targets in Oncology Trials;2024-04-19
5. Diversity Plans and Postmarketing Studies: First Impressions of Anticipated Diversity Requirements in the United States;Therapeutic Innovation & Regulatory Science;2024-04-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3